Assessment of Selected Immunophenotypic Markers in Childhood Non‐Hodgkin's Lymphomas in Ghana: A Possible Tool for Effective Stratification of Patients and Assessment of Survival Outcomes
The survival rate for NHL patients in Ghana is very low, with survival rates declining from 76% at 10 months to 20% at 40 months, with factors significantly associated with poor survival included BCL‐2 expression (poorer survival) and extranodal spread.